Page last updated: 2024-08-21

tripalmitin and acetylcysteine

tripalmitin has been researched along with acetylcysteine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, K; Haack, D; Kienberger, D; Köberle, M; Lochmann, D; Lopes, D; Salar-Behzadi, S; Saurugger, EM; Stehr, M; Zimmer, A1
Becker, K; Hate, S; Hohl, R; Sacher, S; Salar-Behzadi, S; Schiemenz, W; Stocker, E; Zimmer, A1
Becker, K; Haack, D; Koutsamanis, I; Laggner, P; Lopes, DG; Salar-Behzadi, S; Scheibelhofer, O; Stehr, M; Zimmer, A1

Other Studies

3 other study(ies) available for tripalmitin and acetylcysteine

ArticleYear
Advanced stable lipid-based formulations for a patient-centric product design.
    International journal of pharmaceutics, 2016, Jan-30, Volume: 497, Issue:1-2

    Topics: Acetylcysteine; Adult; Chemistry, Pharmaceutical; Computer Simulation; Drug Liberation; Drug Stability; Excipients; Female; Humans; Male; Middle Aged; Particle Size; Polysorbates; Solubility; Taste; Technology, Pharmaceutical; Triglycerides; Young Adult

2016
Application of ICH Q9 Quality Risk Management Tools for Advanced Development of Hot Melt Coated Multiparticulate Systems.
    Journal of pharmaceutical sciences, 2017, Volume: 106, Issue:1

    Topics: Acetylcysteine; Administration, Oral; Antiviral Agents; Drug Carriers; Drug Compounding; Drug Liberation; Excipients; Free Radical Scavengers; Freezing; Particle Size; Polysorbates; Solubility; Spectrophotometry, Infrared; Triglycerides

2017
Microphase separation in solid lipid dosage forms as the cause of drug release instability.
    International journal of pharmaceutics, 2017, Jan-30, Volume: 517, Issue:1-2

    Topics: Acetylcysteine; Crystallization; Drug Compounding; Drug Liberation; Drug Stability; Excipients; Lipids; Particle Size; Phase Transition; Polysorbates; Triglycerides

2017